𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas : Results of a randomized trial

✍ Scribed by Nina Arakelyan; Jean-Philippe Jais; Vincent Delwail; Josette Brière; Marie-Pierre Moles-Moreau; Delphine Sénécal; Christian Berthou; Bernard Desablens; Pierre Colonna; Jean-Marie Andrieu; on behalf of the GOELAMS Hodgkin Lymphoma Network

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
306 KB
Volume
116
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early versus late intensification for pa
Early versus late intensification for patients with high-risk Hodgkin lymphoma—3 Cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation : Five-year results of a randomized trial on behalf of the GOELAMS group
✍ Nina Arakelyan; Christian Berthou; Bernard Desablens; Sophie de Guibert; Vincent 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views
Treatment of patients with advanced or b
Treatment of patients with advanced or bulky Hodgkin disease with a 12-week doxorubicin, bleomycin, vinblastine, and dacarbazine-like chemotherapy regimen followed by extended-field, full-dose radiotherapy : Long-term results of the Groupe Ouest et Est des Leucémies et Autres Maladies de Sang H90-a/b multicenter randomized trial
✍ Malika Djeridane; Stéphane Oudard; Martine Escoffre-Barbe; Laurence Lacotte-Thie 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

## Abstract ## BACKGROUND This Phase II study was performed in patients with advanced or bulky Hodgkin disease (HD) to evaluate the results of a 7‐drug chemotherapy (CT) regimen that was administered over 12 weeks according to 2 randomized modalities followed by high‐dose lymph node irradiation.